Go Pro
→ These 3 Stocks Could Soar as Sam Altman Announces New Venture After OpenAI (From Stansberry Research) (Ad)tc pixel Free NVCT Stock Alerts

Nuvectis Pharma (NVCT) Earnings Date, Estimates & Call Transcripts

Nuvectis Pharma logo
$23.73 -1.46 (-5.80%)
As of 08/28/2026 04:00 PM Eastern
Compare

Nuvectis Pharma Earnings Summary

Nuvectis Pharma announced Q2 2026 earnings on August 4, 2026, reporting an EPS of -$0.30, which missed analysts' consensus estimates of -$0.26 by $0.04. With a trailing EPS of -$1.31, Nuvectis Pharma's earnings are expected to decrease next year, from ($1.01) to ($1.10) per share.

Upcoming Q3
Earnings Date
Nov. 3Before Market OpensEstimated
Consensus EPS
(Aug. 4)
-$0.26
Actual EPS
(Aug. 4)
-$0.30 Missed By -$0.04

Q2 2026 Earnings Resources

NVCT Upcoming Earnings

Nuvectis Pharma's next earnings date is estimated for Tuesday, November 3, 2026, based on past reporting schedules.

Powered by Quartr
Get Nuvectis Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nuvectis Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

NVCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Nuvectis Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.29-$0.29-$0.29
Q2 20261-$0.25-$0.25-$0.25
Q3 20261-$0.23-$0.23-$0.23
Q4 20261-$0.25-$0.25-$0.25

Nuvectis Pharma Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/3/2026
(Estimated)		--------
8/4/2026Q2 2026-$0.2620-$0.30 -$0.0380-$0.30--
5/5/2026Q1 2026-$0.30-$0.26+$0.04-$0.26--
2/11/2026Q4 2025-$0.26-$0.31 -$0.05-$0.31--
11/4/2025Q3 2025-$0.24-$0.44 -$0.20-$0.44--
8/5/2025Q2 2025-$0.25-$0.30 -$0.05-$0.30--
5/6/2025Q1 2025-$0.30-$0.27+$0.03-$0.27--
3/4/2025Q4 2024-$0.28-$0.36 -$0.08-$0.36--
11/5/2024Q3 2024-$0.25-$0.24+$0.01-$0.24--

Nuvectis Pharma Earnings - Frequently Asked Questions

Nuvectis Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2026 based off last year's report dates. Learn more on NVCT's earnings history.

In the previous quarter, Nuvectis Pharma (NASDAQ:NVCT) missed the analysts' consensus estimate of ($0.26) by $0.04 with a reported earnings per share (EPS) of ($0.30). Learn more on analysts' earnings estimate vs. NVCT's actual earnings.

Nuvectis Pharma (NASDAQ:NVCT) has a recorded net income of -$26.44 million. NVCT has generated -$1.31 earnings per share over the last four quarters.

Nuvectis Pharma's earnings are expected to decrease from ($1.01) per share to ($1.10) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:NVCT is sourced from Fiscal.ai, with the most recent quarter reported on 8/4/2026. New results are added as companies report their earnings.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Look at this $5 stock’s address
A small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...
Freedom Financial | Sponsoredtc pixel
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...
Banyan Hill Publishing | Sponsoredtc pixel